Skip to main content
Apply

Respiratory and Infectious Diseases

OCRID Center Investigator, Dr. Avi Mitra Receives NIH Funding to Investigate How Tuberculosis Bacteria Acquire Iron to Survive in the Human Body

11-20-2026


Dr. Avi Mitra, Associate Professor in Oklahoma StateAvi Mitra-Profile University's Department of Microbiology and Molecular Genetics and an investigator with the Oklahoma Center for Respiratory and Infectious Diseases (OCRID), has received a National Institutes of Health (NIH) grant through the National Institute of Allergy and Infectious Diseases (NIAID). The three-year award (June 2026–May 2029), 1R15AI199541, supports his project titled “Molecular Mechanisms of Heme Iron Acquisition by Mycobacterium tuberculosis”. The research investigates how Mycobacterium tuberculosis (Mtb), the bacterium responsible for tuberculosis, acquires essential iron from its human host.

Dr. Mitra is also a previous recipient of an OCRID Pilot Project Award for his research on the molecular components of heme uptake pathways in Mycobacterium tuberculosis. His current NIH-funded project focuses on understanding the processes that allow Mtb to obtain and transport heme-derived iron during infection.

Iron is essential for bacterial growth and survival. However, the human body restricts the availability of this nutrient as part of its natural defense against infection. Mtb has evolved specialized mechanisms to obtain iron from its host, including pathways that utilize heme, an iron-containing molecule found in hemoglobin and other host proteins. Understanding these mechanisms is important for determining how the bacterium survives and persists within the human host.

Dr. Mitra's research team is investigating several key components of Mtb's heme acquisition machinery. One focus is the role of Rv0125, a bacterial protein involved in acquiring heme from host hemoproteins. The team is also examining specialized PPE-family proteins that function as channels in the bacterial outer membrane and their contributions to heme transport. Another important objective is to determine how heme acquisition contributes to Mtb growth within alveolar macrophages, immune cells that serve as a primary site of tuberculosis infection in the lungs. These studies will provide insights into the importance of heme uptake pathways in the interaction between Mtb and host immune cells.

By examining these mechanisms, the research aims to clarify how Mtb obtains iron in the human host and how these processes contribute to bacterial survival, virulence, and disease progression. A better understanding of these pathways could help identify potential targets for future tuberculosis treatments by revealing ways to interfere with the bacterium's ability to acquire essential nutrients.